Limula, an emerging life science tools company specializing in automated Cell and Gene Therapy manufacturing solutions, has appointed Dr. Jonathan Esensten to its Strategic Advisory Board. This announcement follows the unveiling of the design of LimONE, Limula’s flagship product. The company’s proprietary technology combines a bioreactor and centrifuge to support all cell therapy manufacturing steps into a single platform.
Dr Esensten is a physician-scientist who serves as the director of the Advanced Biotherapy Center at Sheba Medical Center, Israel. He has extensive experience in the development and adoption of new technologies for manufacturing of cellular therapy products. During his time at University of California (UCSF) and Sheba, Dr Esensten has successfully led multiple cell therapy projects with academic partners, large biopharma, and small biotechnology firms. He trained in cellular immunology, clinical pathology, and transfusion medicine at UCSF. He was on the faculty of the Department of Laboratory Medicine at UCSF from 2017-2023.
